{{ currentBoardShortName }}
  • Markets
  • Indices
  • Currencies
  • Energy
  • Metals
Markets
As of: {{timeStamp.date}}
{{timeStamp.time}}

Markets

{{ currentBoardShortName }}
  • Markets
  • Indices
  • Currencies
  • Energy
  • Metals
{{data.symbol | reutersRICLabelFormat:group.RICS}}
 
{{data.netChng | number: 4 }}
{{data.netChng | number: 2 }}
{{data | displayCurrencySymbol}} {{data.price | number: 4 }}
{{data.price | number: 2 }}
{{data.symbol | reutersRICLabelFormat:group.RICS}}
 
{{data.netChng | number: 4 }}
{{data.netChng | number: 2 }}
{{data | displayCurrencySymbol}} {{data.price | number: 4 }}
{{data.price | number: 2 }}

Latest Videos

{{ currentStream.Name }}

Related Video

Continuous Play:
ON OFF

The information you requested is not available at this time, please check back again soon.

More Video

Mar 9, 2018

Aurora successful in CanniMed offer; integration to start

Aurora Cannabis facility in Montreal Nov. 24, 2017

Security Not Found

The stock symbol {{StockChart.Ric}} does not exist

See Full Stock Page »

EDMONTON, B.C. -- Aurora Cannabis Inc. says it has been successful in its friendly offer for CanniMed Therapeutics Inc. and will now begin the process of combining the two companies.

The company says 70.66 per cent of CanniMed's shares have been tendered to its offer and that it will now take up and pay for them as soon as possible.

Aurora will issue about 50.6 million shares and pay about $98 million in cash for the CanniMed Shares tendered as of Thursday.

The offer for the remaining outstanding shares has also been extended by 15 days to 11:59 PT on March 25

Aurora struck a stock-and-cash deal valued at $1.1 billion to buy CanniMed in January.

The agreement ended a sometimes-bitter takeover battle between the marijuana companies.